The only current adjuvant systemic treatment option in TNBC is chemotherapy. There is no defined standard chemotherapy, and chemotherapy use should not be different for TNBC and non-TNBC
Patients with triple negative breast cancer / Di Leo A; Oakman C; Moretti E; Galardi F; Biagioni C; Santarpia. - In: THE BREAST. - ISSN 0960-9776. - ELETTRONICO. - (2011), pp. S13-S14.
Patients with triple negative breast cancer.
MORETTI, ERICA;
2011
Abstract
The only current adjuvant systemic treatment option in TNBC is chemotherapy. There is no defined standard chemotherapy, and chemotherapy use should not be different for TNBC and non-TNBC
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
